Biotech Values

[zipjet]

teva is up because marth did a good job imo explaining how copaxone won't be cannabalized to a significant degree by oral agents

A 15% increase in pricing* of Copaxone, their biggest profit item, did not hurt either since it will all flow to the bottom line.



ij

* Just a guess but I doubt there is any significant cost increase that is being offset.

====

Edit - looks like we beat this point to death.